Sastravi

Sastravi combines Carbidopa, Entacapone, and Levodopa for oral use. This medication is designed to manage symptoms of Parkinson's disease by supporting dopamine regulation in the brain. Ideal for those seeking comprehensive symptom relief.

Sastravi is primarily used to treat Parkinson's disease. The combination of Carbidopa, Entacapone, and Levodopa works to improve motor function and reduce tremors. This medication is often prescribed to individuals experiencing symptoms such as stiffness, slow movement, and balance issues. It helps to replenish dopamine levels in the brain, which are typically depleted in Parkinson's patients.

Common effects of Sastravi may include improved mobility and reduced tremors. Users often report better control over movement and a decrease in stiffness. Some individuals may experience mild side effects such as nausea, dizziness, or fatigue. These effects vary and should be discussed with a healthcare provider.

Sastravi should be handled with care and stored properly to maintain its effectiveness. It is important to follow the prescribed dosage and administration instructions. Avoid sudden discontinuation without medical advice. Inform your healthcare provider about any pre-existing conditions or other medications you are taking.

Sastravi may interact with certain medications, including other Parkinson's treatments, antidepressants, and blood pressure medications. Alcohol and certain foods may also affect its efficacy. Always consult a healthcare provider before starting or stopping any medication. Be aware of potential interactions with iron supplements and vitamin B6.